Title:
【発明の名称】プロスタグランジンアゴニスト及び骨障害治療へのそれらの使用
Document Type and Number:
Japanese Patent JP2001519414
Kind Code:
A
Abstract:
This invention relates to prostaglandin agonists, methods of using such prostaglandin agonists, pharmaceutical compositions containing such prostaglandin agonists and kits containing such prostaglandin agonists. The prostaglandin agonists are useful for the treatment of bone disorders including osteoporosis.
More Like This:
| JP2014156487 | ANTIBODY TO OX-2/CD200 AND USE THEREOF |
| JP2004522798 | Method for Producing Fine Particles Containing Metoprolol |
| WO/1997/041090 | INORGANIC ION RECEPTOR-ACTIVE COMPOUNDS |
Inventors:
Cameron, Kim Barley Oakie
Lev Car, Bruce Allen
Rosati, Robert Lewis
Lev Car, Bruce Allen
Rosati, Robert Lewis
Application Number:
JP2000515873A
Publication Date:
October 23, 2001
Filing Date:
October 05, 1998
Export Citation:
Assignee:
Pfizer Inc.
International Classes:
A61K31/138; A61K31/18; A61K31/195; A61K31/343; A61K31/357; A61K31/36; A61K31/381; A61K31/40; A61K31/4015; A61K31/4025; A61K31/415; A61K31/4155; A61K31/4164; A61K31/4174; A61K31/4178; A61K31/42; A61K31/4245; A61K31/425; A61K31/426; A61K31/427; A61K31/433; A61K31/435; A61K31/44; A61K31/4402; A61K31/4406; A61K31/4409; A61K31/4418; A61K31/4427; A61K31/443; A61K31/4433; A61K31/4436; A61K31/4439; A61K31/444; A61K31/4535; A61K31/495; A61K31/496; A61K31/4965; A61K31/497; A61K31/505; A61K31/506; A61K31/517; A61K31/53; A61K31/5377; A61K31/557; A61K31/663; A61P13/12; A61P19/00; A61P19/08; A61P19/10; C07D233/06; A61P27/06; A61P43/00; C07C311/06; C07C311/08; C07C311/13; C07C311/19; C07D207/38; C07D213/38; C07D213/70; C07D213/71; C07D231/12; C07D233/84; C07D239/24; C07D239/26; C07D241/12; C07D261/10; C07D265/30; C07D265/32; C07D271/08; C07D271/12; C07D277/20; C07D277/28; C07D277/36; C07D277/56; C07D277/84; C07D285/10; C07D307/81; C07D317/58; C07D317/60; C07D319/18; C07D333/34; C07D333/40; C07D401/12; C07D403/12; C07D405/12; C07D409/04; C07D409/12; C07D409/14; C07D413/12; C07D413/14; C07D417/12; C07D417/14; A61K; C07C; C07D; (IPC1-7): C07C311/13; A61K31/18; A61K31/357; A61K31/36; A61K31/381; A61K31/40; A61K31/415; A61K31/4155; A61K31/4164; A61K31/42; A61K31/4245; A61K31/425; A61K31/426; A61K31/427; A61K31/433; A61K31/435; A61K31/4406; A61K31/443; A61K31/4436; A61K31/4439; A61K31/497; A61K31/505; A61K31/506; A61K31/517; A61P19/08; A61P19/10; A61P43/00; C07D207/38; C07D213/71; C07D231/12; C07D233/84; C07D239/24; C07D241/12; C07D261/10; C07D271/08; C07D277/36; C07D277/56; C07D285/10; C07D307/81; C07D317/60; C07D319/18; C07D333/34; C07D333/40; C07D401/12; C07D403/12; C07D405/12; C07D409/12; C07D413/14; C07D417/12; C07D417/14
Attorney, Agent or Firm:
Hiroshi Kobayashi